Sotera Health Company (SHC)
Automate Your Wheel Strategy on SHC
With Tiblio's Option Bot, you can configure your own wheel strategy including SHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SHC
- Rev/Share 3.9032
- Book/Share 1.4603
- PB 8.5117
- Debt/Equity 0.0
- CurrentRatio 2.4558
- ROIC 0.0304
- MktCap 3528317650.0
- FreeCF/Share 0.2649
- PFCF 46.966
- PE 142.0934
- Debt/Assets 0.0
- DivYield 0
- ROE 0.058
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | SHC | Goldman | Neutral | Buy | -- | $17 | May 5, 2025 |
| Initiation | SHC | Goldman | -- | Neutral | -- | $14 | Dec. 6, 2024 |
News
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript
Published: May 02, 2025 by: Seeking Alpha
Sentiment: Neutral
Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call.
Read More
Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago.
Read More
Sotera Health Reports First-Quarter 2025 Results
Published: May 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2025.
Read More
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately.
Read More
Sotera Health Has A Great Deleveraging Path Ahead
Published: April 08, 2025 by: Seeking Alpha
Sentiment: Positive
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging.
Read More
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call.
Read More
Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
CLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2024 and its initial 2025 outlook.
Read More
Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
Published: February 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.
Read More
About Sotera Health Company (SHC)
- IPO Date 2020-11-20
- Website https://soterahealth.com
- Industry Medical - Diagnostics & Research
- CEO Mr. Michael B. Petras Jr.
- Employees 3000